Lidocaine Ointment USP recall (Preferred Pharmaceuticals, Inc.)
DrugClass IIOngoing
Summary: Preferred Pharmaceuticals, Inc. is recalling Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05. Reason: Failed Content Uniformity Specifications.
What is being recalled
Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05
Why
Failed Content Uniformity Specifications
How serious is it
Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.
Where it was sold
USA Nationwide
How to tell if yours is affected
Lot #: F1925G, Expiry: 4/30/2027; Lot #: E0925T, Expiry: 4/30/2027; Lot # D3025M, Expiry: 4/30/2027; Lot #: D0825D, Expiry: 4/30/2027.
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0013-2027 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class II |
| Status | Ongoing |
| Recall started | September 28, 2026 |
| Reported | October 14, 2026 |
| Company | Preferred Pharmaceuticals, Inc. |
| Company location | Anaheim, CA, United States |
| Initiated by | Voluntary: Firm initiated |
| Quantity | N/A |
More recalls from Preferred Pharmaceuticals, Inc. · all drug recalls · recalls from September 2026